Publications by authors named "Peter Laverman"

Claim this Profile
A
Assessment of quality control and effect of radiolysis on the in vivo biodistribution of [Lu]Lu-PSMA-I&T.
Eline L Hooijman, Carolline M Ntihabose, Stijn L W Koolen, Maryana Handula, Savanne Beekman, Peter Laverman

EJNMMI Radiopharm Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiopharmaceutical formulation and preliminary clinical dosimetry of [Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy.
Taraneh Sadat Zavvar, Anton Amadeus Hörmann, Mark Konijnenberg, Martin Kraihammer, Christian Mair, Peter Laverman

Eur J Nucl Med Mol Imaging· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis.
Wessel F Theeuwes, Irene Di Ceglie, Daphne N Dorst, Arjen B Blom, Desiree L Bos, Peter Laverman

Arthritis Res Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand.
Yvonne H W Derks, Melline G M Schilham, Mark Rijpkema, Esther M M Smeets, Helene I V Amatdjais-Groenen, Peter Laverman

Eur J Nucl Med Mol Imaging· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Oliver C Kiss, Peter J H Scott, Martin Behe, Ivan Penuelas, Jan Passchier, Peter Laverman

EJNMMI Radiopharm Chem· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated Application and Removal of Polyisocyanopeptide Hydrogel Wound Dressings in a Splinted Full-Thickness Wound Model.
Roel C Op 't Veld, Lieke Joosten, Peter Laverman, Ewald M Bronkhorst, John A Jansen

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of -Terminal Peptide Modifications on In Vitro and In Vivo Properties of Lu-Labeled Peptide Analogs Targeting CCK2R.
Anton Amadeus Hörmann, Maximilian Klingler, Christine Rangger, Christian Mair, Lieke Joosten, Peter Laverman

Pharmaceutics· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EANM guideline on quality risk management for radiopharmaceuticals.
Nic Gillings, Olaug Hjelstuen, Martin Behe, Clemens Decristoforo, Philip H Elsinga, Peter Laverman

Eur J Nucl Med Mol Imaging· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy.
Daphne N Dorst, Mark Rijpkema, Mijke Buitinga, Birgitte Walgreen, Monique M A Helsen, Peter Laverman

Rheumatology (Oxford)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer.
Yvonne H W Derks, Sanne A M van Lith, Helene I V Amatdjais-Groenen, Lieke W M Wouters, Annemarie Kip, Peter Laverman

Eur J Nucl Med Mol Imaging· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man.
Bastiaan M Privé, Yvonne H W Derks, Florian Rosar, Gerben M Franssen, Steffie M B Peters, Peter Laverman

Eur J Nucl Med Mol Imaging· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Emerson Bernardes, Peter Caravan, R Michael van Dam, Winnie Deuther-Conrad, Beverley Ellis, Peter Laverman

EJNMMI Radiopharm Chem· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strain-Promoted Azide-Alkyne Cycloaddition-Based PSMA-Targeting Ligands for Multimodal Intraoperative Tumor Detection of Prostate Cancer.
Yvonne H W Derks, Mark Rijpkema, Helene I V Amatdjais-Groenen, Cato C Loeff, Kim E de Roode, Peter Laverman

Bioconjug Chem· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development.
Daphne N Dorst, Marti Boss, Mark Rijpkema, Birgitte Walgreen, Monique M A Helsen, Peter Laverman

Pharmaceutics· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photosensitizer-based multimodal PSMA-targeting ligands for intraoperative detection of prostate cancer.
Yvonne H W Derks, Mark Rijpkema, Helene I V Amatdjais-Groenen, Annemarie Kip, Gerben M Franssen, Peter Laverman

Theranostics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimised GMP-compliant production of [F]DPA-714 on the Trasis AllinOne module.
Klaudia A Cybulska, Vera Bloemers, Lars R Perk, Peter Laverman

EJNMMI Radiopharm Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.
Nic Gillings, Olaug Hjelstuen, Jim Ballinger, Martin Behe, Clemens Decristoforo, Peter Laverman

EJNMMI Radiopharm Chem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis.
Daphne N Dorst, Mark Rijpkema, Marti Boss, Birgitte Walgreen, Monique M A Helsen, Peter Laverman

Rheumatology (Oxford)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using Ga-RGD PET/CT.
Daphne Lobeek, Frédérique C M Bouwman, Erik H J G Aarntzen, Janneke D M Molkenboer-Kuenen, Uta E Flucke, Peter Laverman

J Nucl Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EANM guideline on the validation of analytical methods for radiopharmaceuticals.
Nic Gillings, Sergio Todde, Martin Behe, Clemens Decristoforo, Philip Elsinga, Peter Laverman

EJNMMI Radiopharm Chem· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Huntington's Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers.
Klaudia Cybulska, Lars Perk, Jan Booij, Peter Laverman, Mark Rijpkema

Molecules· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting the Concept of Multivalency with Ga- and Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R Expression.
Dominik Summer, Christine Rangger, Maximilian Klingler, Peter Laverman, Gerben M Franssen

Contrast Media Mol Imaging· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritis.
Tessa van der Geest, Debbie M Roeleveld, Birgitte Walgreen, Monique M Helsen, Tapan K Nayak, Peter Laverman

Rheumatology (Oxford)· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response Monitoring with [F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases.
Sandra Heskamp, Linda Heijmen, Danny Gerrits, Janneke D M Molkenboer-Kuenen, Edwin G W Ter Voert, Peter Laverman

Mol Imaging Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.
Tessa van der Geest, Peter Laverman, Danny Gerrits, Birgitte Walgreen, Monique M Helsen

J Nucl Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis